AP NEWS
Click to copy
Press release content from Business Wire. The AP news staff was not involved in its creation.
Click to copy
PRESS RELEASE: Paid content from Business Wire
Press release content from Business Wire. The AP news staff was not involved in its creation.

The U.S. Fibromyalgia Market 2014-2019 & 2024: Pipeline Products, Epidemiology, Key Products Marketed, Market Valuations & Forecast, Drugs Sales & Market Shares, Competitive Landscape - ResearchAndMarkets.com

July 24, 2019

DUBLIN--(BUSINESS WIRE)--Jul 24, 2019--

The “US Fibromyalgia Market and Competitive Landscape - 2019” report has been added to ResearchAndMarkets.com’s offering.

This latest research provides comprehensive insights into Fibromyalgia pipeline products, Fibromyalgia epidemiology, Fibromyalgia market valuations and forecast, Fibromyalgia drugs sales and competitive landscape in the US.

The research is classified into seven sections - Fibromyalgia treatment options, pipeline products, market analysis comprising of epidemiology, key products marketed, market valuations and forecast, drugs sales and market shares.

Research Scope

Benefits of this Research

Key Topics Covered

1) Fibromyalgia Treatments

2) Fibromyalgia Pipeline

3) US Fibromyalgia Epidemiology

4) Marketed Drugs for Fibromyalgia in US

5) US Fibromyalgia Market Size and Forecast

6) US Fibromyalgia Products Sales and Forecast

7) US Fibromyalgia Market Competitive Landscape

8) Methodology

List of Tables

1. Fibromyalgia Phase 3 Clinical Trials, 2019

2. Fibromyalgia Phase 2 Clinical Trials, 2019

3. Fibromyalgia Phase 1 Clinical Trials, 2019

4. Fibromyalgia Epidemiology, US, 2014 - 2024

5. Marketed Drugs for Fibromyalgia, US, 2018

6. Fibromyalgia Market Size and Forecast ($), US, 2014 - 2024

7. Fibromyalgia Product Sales ($), US, 2014 - 2024

List of Figures

1. Fibromyalgia Epidemiology, US, 2014 - 2024

2. Fibromyalgia Market Size and Forecast ($), US, 2014 - 2024

3. Fibromyalgia Products Market Share (%), US, 2018

For more information about this report visit https://www.researchandmarkets.com/r/t2golr

View source version on businesswire.com:https://www.businesswire.com/news/home/20190724005377/en/

CONTACT: ResearchAndMarkets.com

Laura Wood, Senior Press Manager

press@researchandmarkets.com

For E.S.T Office Hours Call 1-917-300-0470

For U.S./CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900

Related Topics:Musculoskeletal Disorders Drugs

KEYWORD:

INDUSTRY KEYWORD: HEALTH PHARMACEUTICAL

SOURCE: Research and Markets

Copyright Business Wire 2019.

PUB: 07/24/2019 05:49 AM/DISC: 07/24/2019 05:49 AM

http://www.businesswire.com/news/home/20190724005377/en

All contents © copyright 2019 The Associated Press. All rights reserved.